Clinical Trial

Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities

New manufacturing capacity allows Establishment Labs to provide over half the current world demand for breast implants and supports upcoming…

12 months ago

GenHealth.AI Accelerates into Healthcare AI Market with New Funding, Advisor Appointments and Use Cases Across Healthcare

AI Start-up Pioneering Generative AI for Healthcare Receives $13M in Early Funding, Adds Industry Luminaries as Advisors, and Kicks off…

12 months ago

Arthritis Foundation Receives $1 Million Gift from Longtime Partner Alpha Omicron Pi Fraternity

ATLANTA, GA / ACCESSWIRE / July 19, 2023 / The Arthritis Foundation announced it has received its largest gift to-date…

12 months ago

Abeona Therapeutics Joins Rare Disease Company Coalition

CLEVELAND, July 19, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has joined the Rare…

12 months ago

Zymeworks To Host Second Quarter 2023 Results Conference Call

VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional…

12 months ago

Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023

– Conference call and webcast to be held on July 26, 2023, at 8am ET – BOSTON, July 19, 2023…

12 months ago

Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040There are…

12 months ago

First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering

BOCA RATON, Fla., July 19, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”),…

12 months ago

Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as Interim Chief Financial Officer

NEW YORK and LONDON, July 19, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing…

12 months ago

Emergex Reports Promising Data from Completed Swiss Phase I Trial of CoronaTcP™, T Cell-Priming Immune Set-Point Candidate for Betacoronaviruses

First-in-human intradermal administration of CoronaTcP™ was generally well-toleratedEvidence for generation of virus-specific effector and memory CD8+ T cellsData reinforce findings…

12 months ago